Evidence map›Paper›PMID 28094796›Full record

ArticleThe ISME journal2017

The evolution of no-cost resistance at sub-MIC concentrations of streptomycin in Streptomyces coelicolor.

Sanne Westhoff, Tim Marijn van Leeuwe, Omar Qachach, Zheren Zhang, Gilles Philippus van Wezel, Daniel Eric Rozen

Open access · bronzeAbstract read
In one paragraph

Article in The ISME journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
6.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 88 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Heterogeneous subpopulations inFrontiers in cellular and infection microbiology · 2025
    Article
  12. Article
  13. Substrate geometry affects population dynamics in a bacterial biofilm.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Antibiotic perseverance increases the risk of resistance development.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  19. Article
  20. Variability in Adaptive Resistance ofAntibiotics (Basel, Switzerland) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Sanne WesthoffInstitute of Biology, Leiden University, Leiden, The Netherlands.
Tim Marijn van LeeuweInstitute of Biology, Leiden University, Leiden, The Netherlands.
Omar QachachInstitute of Biology, Leiden University, Leiden, The Netherlands.
Zheren ZhangInstitute of Biology, Leiden University, Leiden, The Netherlands.
Gilles Philippus van WezelInstitute of Biology, Leiden University, Leiden, The Netherlands.
Daniel Eric RozenInstitute of Biology, Leiden University, Leiden, The Netherlands.
Leiden University · NL

Funding

Biotechnology and Biological Sciences Research Council BB/J006009/1
6 · The paper itself

Abstract

At the high concentrations used in medicine, antibiotics exert strong selection on bacterial populations for the evolution of resistance. However, these lethal concentrations may not be representative of the concentrations bacteria face in soil, a recognition that has led to questions of the role of antibiotics in soil environments as well as the dynamics of resistance evolution during sublethal challenge. Here we examine the evolution of resistance to sub-minimal inhibitory concentrations (sub-MIC) of streptomycin in the filamentous soil bacterium Streptomyces coelicolor. First, we show that spontaneous resistance to streptomycin causes an average fitness deficit of ~21% in the absence of drugs; however, these costs are eliminated at concentrations as low as 1/10 the MIC of susceptible strains. Using experimental evolution, we next show that resistance to >MIC levels of streptomycin readily evolves when bacteria are exposed to sub-MIC doses for 500 generations. Furthermore, the resistant clones that evolved at sub-MIC streptomycin concentrations carry no fitness cost. Whole-genome analyses reveal that evolved resistant clones fixed some of the same mutations as those isolated at high drug concentrations; however, all evolved clones carry additional mutations and some fixed mutations that either compensate for costly resistance or have no associated fitness costs. Our results broaden the conditions under which resistance can evolve in nature and suggest that rather than low-concentration antibiotics acting as signals, resistance evolves in response to antibiotics used as weapons.

Indexed as

Anti-Bacterial AgentsBiological EvolutionDrug Resistance, BacterialMutationSoil MicrobiologyStreptomyces coelicolorStreptomycinAnti-Bacterial AgentsStreptomycin

Identifiers

PMID28094796
PMCPMC5437928
OpenAlexW2949375600

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.